Peter Hoang - President & CEO @ Marker Therapeutics

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Peter Hoang is the President and CEO at Marker Therapeutics.

Number of Current Jobs

Number of Past Jobs

is the

President & CEO

. Additionally,

has had

past jobs including

President & Chief Executive Officer

Organization Name	Title At Company	Start Date	End Date
TapImmune	President & Chief Executive Officer	2017	2018
Bellicum Pharmaceuticals	Senior Vice President, Business Development & Strategy	2014	2017
The University of Texas M.D. Anderson Cancer Center	Managing Director, Innovations (Strategic Industry Ventures)	2012	2014
CIT Group	Managing Director	2010	2012
CIBC World Markets	Executive Director	2005	2010
Oppenheimer & Co.	Executive Director	2005	2010
JP Morgan	Associate	2004	2005
Merrill Lynch	Vice President	2000	2002
Deutsche Bank	Associate	1996	2000

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

holds

board and advisor roles including

Director, Board of Directors

Board Director

, and

Chairman, Board of Advisors

Organization Name	Title At Company	Start Date	End Date
Kiromic Biopharma	Board Director	2017	2019
TapImmune	Board Director	2017	2018
Toost Control Corp.	Board member and President	2008	2013

Hub Name	CB Rank (Hub)
Cancer Prevention and Research Institute of Texas Portfolio Companies	90,513
Therapeutics Public Companies With Less Than $500M in Revenue	29,661
Biotechnology Public Companies With Fewer Than 50 Employees	23,628
National Institutes of Health Portfolio Companies	35,341
Companies That Exited in 1998	22,426
Therapeutics Public Companies With More Than 10 Employees	20,903
Therapeutics Public Companies With Less Than $50M in Revenue	99,822
Therapeutics Public Companies With Less Than $1B in Revenue	29,751
Companies that Went Public in 1998	34,918
Therapeutics Public Companies With Fewer Than 1000 Employees	18,323